NCT05760768

Brief Summary

A single center, randomized controlled trial was conducted to investigate whether individualized exercise guidance was more effective in improving pregnancy outcomes in normal pregnant women. What's more, the trial was also conducted to find out whether there is a mediating effect between prenatal exercise and pregnancy outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
326

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 8, 2023

Completed
Last Updated

March 8, 2023

Status Verified

November 1, 2021

Enrollment Period

2 months

First QC Date

February 20, 2023

Last Update Submit

March 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • macrosomia

    Neonatal birthweight is more than 4000 grams.

    From date of enrollment until the date of delivery, assessed up to 28 weeks.

  • gestation weight gain(GWG)

    Weight before delivery minus weight before pregnancy.

    From date of enrollment until the date of delivery, assessed up to 28 weeks.

Secondary Outcomes (2)

  • postpartum weight retention(PPWR)

    From date of enrollment until the date of 42 days postpartum, assessed up to 34 weeks.

  • diastasis recti abdominis(RDA)

    From date of enrollment until the date of 42 days postpartum, assessed up to 34 weeks.

Study Arms (2)

Individualized exercise guidance group

EXPERIMENTAL

Participants accept individualized exercise guidance. They are also managed continuously through WeChat group chat during prenatal clinical interval.

Behavioral: Individualized exercise guidance

Standard clinic prenatal care (control) group

NO INTERVENTION

Participants accept regular routine prenatal care following Chinese standard.

Interventions

Participants accept individualized exercise guidance. They are also managed continuously through WeChat group chat during prenatal clinical interval.

Individualized exercise guidance group

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged between 18 and 45 years.
  • With singleton pregnancy.
  • Second trimester.
  • No contraindications to exercise during pregnancy.
  • Be able to use smart phone for chatting, read and write basic Chinese.
  • Volunteer for research.

You may not qualify if:

  • Adverse pregnancy reaction, such as abdominal pain, vaginal bleeding and so on.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of ob gyn, Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

Related Publications (1)

  • Yang X, Wang G, Liu N, Wang Y, Zhang S, Lin H, Zhu C, Liu L, Sun Y, Ma L. Mediating effect of gestational weight gain on the preventive effect of exercise during pregnancy on macrosomia: a randomized clinical trial. BMC Pregnancy Childbirth. 2024 May 22;24(1):384. doi: 10.1186/s12884-024-06527-7.

MeSH Terms

Conditions

Gestational Weight GainNegotiatingFetal Macrosomia

Condition Hierarchy (Ancestors)

Weight GainBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsCommunicationBehaviorDiabetes, GestationalPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFetal DiseasesPregnancy in DiabeticsCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesBirth Weight

Study Officials

  • Liangkun Ma

    Peking union medical college hosiptal

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2023

First Posted

March 8, 2023

Study Start

December 1, 2021

Primary Completion

January 31, 2022

Study Completion

September 30, 2022

Last Updated

March 8, 2023

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations